George A Eldridge is of Aerovate Therapeutics, Inc.. Currently has a direct ownership of 5,022 shares of AVTE, which is worth approximately $13,358. The most recent transaction as insider was on Jun 14, 2024, when has been sold 15,000 shares (Common Stock) at a price of $25.03 per share, resulting in proceeds of $375,450. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.02K
0% 3M change
156.22% 12M change
Total Value Held $13,358

George A Eldridge Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2024
SELL
Open market or private sale
$375,450 $25.03 p/Share
15,000 Reduced 74.92%
5,022 Common Stock
Jun 14 2024
BUY
Exercise of conversion of derivative security
$32,100 $2.14 p/Share
15,000 Added 42.83%
20,022 Common Stock
Apr 10 2024
SELL
Open market or private sale
$203,775 $27.17 p/Share
7,500 Reduced 79.28%
1,960 Common Stock
Apr 10 2024
BUY
Exercise of conversion of derivative security
$16,050 $2.14 p/Share
7,500 Added 44.22%
9,460 Common Stock
Apr 01 2024
SELL
Open market or private sale
$390,218 $31.23 p/Share
12,495 Reduced 86.44%
1,960 Common Stock
Apr 01 2024
BUY
Exercise of conversion of derivative security
$26,739 $2.14 p/Share
12,495 Added 46.36%
14,455 Common Stock
Mar 13 2024
SELL
Open market or private sale
$50,440 $25.02 p/Share
2,016 Reduced 50.7%
1,960 Common Stock
Mar 13 2024
BUY
Exercise of conversion of derivative security
$4,314 $2.14 p/Share
2,016 Added 33.64%
3,976 Common Stock
Mar 12 2024
SELL
Open market or private sale
$51,377 $25.05 p/Share
2,051 Reduced 51.13%
1,960 Common Stock
Mar 12 2024
BUY
Exercise of conversion of derivative security
$4,389 $2.14 p/Share
2,051 Added 33.83%
4,011 Common Stock
Mar 11 2024
SELL
Open market or private sale
$88,468 $25.77 p/Share
3,433 Reduced 63.66%
1,960 Common Stock
Mar 11 2024
BUY
Exercise of conversion of derivative security
$7,346 $2.14 p/Share
3,433 Added 38.9%
5,393 Common Stock
Mar 08 2024
SELL
Open market or private sale
$2,850 $25.0 p/Share
114 Reduced 5.5%
1,960 Common Stock
Mar 08 2024
BUY
Exercise of conversion of derivative security
$243 $2.14 p/Share
114 Added 5.21%
2,074 Common Stock
Mar 07 2024
SELL
Open market or private sale
$559,650 $25.0 p/Share
22,386 Reduced 91.95%
1,960 Common Stock
Mar 07 2024
BUY
Exercise of conversion of derivative security
$47,906 $2.14 p/Share
22,386 Added 47.9%
24,346 Common Stock
Dec 12 2022
SELL
Open market or private sale
$300,400 $30.04 p/Share
10,000 Reduced 83.61%
1,960 Common Stock
Dec 12 2022
BUY
Exercise of conversion of derivative security
$21,400 $2.14 p/Share
10,000 Added 45.54%
11,960 Common Stock
Dec 09 2022
SELL
Open market or private sale
$98,153 $24.73 p/Share
3,969 Reduced 66.94%
1,960 Common Stock
Dec 09 2022
BUY
Exercise of conversion of derivative security
$8,493 $2.14 p/Share
3,969 Added 40.1%
5,929 Common Stock
Dec 08 2022
SELL
Open market or private sale
$259,797 $21.63 p/Share
12,011 Reduced 85.97%
1,960 Common Stock
Dec 08 2022
BUY
Exercise of conversion of derivative security
$25,703 $2.14 p/Share
12,011 Added 46.23%
13,971 Common Stock
Dec 07 2022
SELL
Open market or private sale
$231,459 $19.89 p/Share
11,637 Reduced 85.59%
1,960 Common Stock
Dec 07 2022
BUY
Exercise of conversion of derivative security
$24,903 $2.14 p/Share
11,637 Added 46.12%
13,597 Common Stock
Nov 30 2022
SELL
Open market or private sale
$1,620 $19.06 p/Share
85 Reduced 4.16%
1,960 Common Stock
GAE

George A Eldridge

Boston, MA

Track Institutional and Insider Activities on AVTE

Follow Aerovate Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTE shares.

Notify only if

Insider Trading

Get notified when an Aerovate Therapeutics, Inc. insider buys or sells AVTE shares.

Notify only if

News

Receive news related to Aerovate Therapeutics, Inc.

Track Activities on AVTE